Effects of Physiotherapy Via Telerehabilitation in Patients With COVID-19

COVID-19 Clinical Trial

Official title:

Effects of Physiotherapy Via Telerehabilitation on Cardiopulmonary, Physical, and Psychological Functions in Patients With COVID-19: A Randomized Controlled Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT06251011
• Other study ID #: EC014/2565
• Status: Active, not recruiting
• Phase: N/A
• Start date: February 9, 2024
• Est. completion date: June 15, 2024

Study information

• Verified date: February 2024
• Source: Chulabhorn Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to evaluate the effects of Physiotherapy Via Video Calls on Cardiopulmonary Functions, Physical Function, Cognitive Function, Activity Daily Livings, and Quality of Life in Patients With COVID-19.

Description:

A 2-armed, parallel-group, randomized controlled trial was conducted at Chulabhorn Hospital, Thailand on a convenience sample of patients who tested positive for COVID-19 using RT-PCR.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 30
• Est. completion date: June 15, 2024
• Est. primary completion date: June 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 60 Years

Eligibility

Inclusion Criteria:

• Age between 20-60 years old
• Positive in COVID-19 testing
• Good communication and understanding
• Independent mobility

Exclusion Criteria:

• Cannot complete the study protocol

Related Conditions & MeSH terms

• Cardiopulmonary Function
• COVID-19
• Long COVID-19
• Physical Function

Intervention

Behavioral:
• Exercise training
Physical therapy training via video call An advise and a leaflet for cardiopulmonary rehabilitation

Locations

Country	Name	City	State
Thailand	Chulabhorn hospital	Lak Si	Bangkok

Sponsors (1)

Lead Sponsor	Collaborator
Chulabhorn Hospital

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cardiopulmonary function	using Cardiopulmonary exercise testing (CPET)	at day 28 and 90 after positive in COVID-19 testing
Primary	Patient's quality of life	using the The World Health Organization Quality of Life (WHOQOL-BREF-THAI) 26 items; the final score ranges from 24-120; higher score means participants satisfied with the quality of life.	at day 3 and 21 after positive in COVID-19 testing
Primary	Functional capacity	using Duke Activity status index The final score ranges between zero and 58.2 points; The higher the score, the better the functional capacity.	at day 3 and 21 after positive in COVID-19 testing
Primary	Anxiety and depression	using Hospital Anxiety and Depression Scale (HADS) The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). A total subscale score of >8 points out of a possible 21 denotes considerable symptoms of anxiety or depression.	at day 3 and 21 after positive in COVID-19 testing
Primary	Insomnia	using Insomnia Severity Index (ISI) The final score ranges between zero and 28 points. The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).	at day 3 and 21 after positive in COVID-19 testing
Primary	Cognitive function	using Thai Mental State Examination The final score ranges between zero and 30 points. A score of 25 or higher is classed as normal. If the score is below 24, the result is usually considered to be abnormal, indicating possible cognitive impairment.	at day 3 and 21 after positive in COVID-19 testing
Primary	Muscle strength	using 1-minute sit to stand	at day 3 and 21 after positive in COVID-19 testing